CompletedNot Applicable

Conservative Treatment and Ultrasound Guided Injection for Treatment Meralgia Paresthetica

54 participantsStarted 2014-01-01

Plain-language summary

Meralgia paresthetica (MP) is an entrapment mononeuropathy of the lateral femoral cutaneous nerve (LFCN), where conservative treatment options are not always sufficient. The aim of this study was to evaluate the efficacy of ultrasound (US) guided lateral femoral cutaneous nerve injection in the management of meralgia paresthetica by comparing with transcutaneous electrical nerve stimulation (TENS) therapy and sham transcutaneous electrical nerve stimulation therapy.

Who can participate

Age range42 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * Patients diagnosed with LFCN entrapment confirmed by clinical and electrophysiological findings Exclusion criteria * Secondary entrapment neuropathy * Malignancy * Pregnancy * Infection in the inguinal region or dermatitis * Lumbar radiculopathy * Cardiac pacemakers * Polyneuropathy

What they're measuring

Visual Analog Scale

Timeframe: 1 months

painDETECT questionnaire

Timeframe: 1 months

Semmes-Weinstein monofilament test

Timeframe: 1 months

Trial details

NCT IDNCT04004052

SponsorFatih Sultan Mehmet Training and Research Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-01-01

View on ClinicalTrials.gov More Meralgia Paresthetica trials